MDVs to the rescue: How autophagy-deficient cancer cells adapt to defective mitophagy
- PMID: 34314695
- DOI: 10.1016/j.devcel.2021.06.022
MDVs to the rescue: How autophagy-deficient cancer cells adapt to defective mitophagy
Abstract
Cancers are dependent on mitochondria, the powerhouse of the cell, and autophagy, the mechanism to preserve mitochondrial quality and function. In this issue of Developmental Cell, Towers et al. identify mitochondria-derived vesicles (MDVs) as a new adaptive mechanism enabling cancer cells to compensate for autophagy loss and to maintain mitochondrial function.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests E.W. is a founder of Vescor Therapeutics and a stockholder in Forma Therapeutics.
Comment on
-
Mitochondrial-derived vesicles compensate for loss of LC3-mediated mitophagy.Dev Cell. 2021 Jul 26;56(14):2029-2042.e5. doi: 10.1016/j.devcel.2021.06.003. Epub 2021 Jun 24. Dev Cell. 2021. PMID: 34171288 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
